Home Compare COLO-B.CO vs EW
Stock Comparison · Structural lead, mixed market

Coloplast A/S vs Edwards Lifesciences: Which Stock Looks Stronger in 2026?

Edwards Lifesciences leads structurally, with profitability as the clearest single gap between the two profiles. The market setup broadly confirms the structural lead — Edwards Lifesciences holds the more constructive position. That puts structure and market broadly in agreement — Edwards Lifesciences's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (COLO-B.CO: STOXX 600, EW: S&P 500).

Updated 2026-08-16

Profitability remains the main source of distance in the comparison. The overall score gap is 9 points in favour of Edwards Lifesciences Corporation.

Trajectory Similarity
0.76
Similar
Peer-set rank: #1
within Coloplast A/S's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

Most of the shared profile comes through operating margin level and revenue growth trajectory.

Similarity drivers
operating margin levelrevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
COLO-B.CO
Coloplast A/S
35
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
EW
Edwards Lifesciences Corporation
44
Peer-Score
Signal qualityMedium
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: COLO-B.CO vs EW Profitability 35 57 Stability 50 47 Valuation 30 38 Growth 27 28 COLO-B.CO EW
Gap Ranking
#1 Profitability +22
#2 Valuation +8
#3 Stability +3
#4 Growth +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for COLO-B.CO and EW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer COLO-B.COEW Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where COLO-B.CO and EW each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY COLO-B.CO Lower · below norm 0th 50th 100th 67 pct gap EW Elevated · above norm 0th 50th 100th 7th 74th
Today COLO-B.CO sits in the lower portion of its own 5-year history (7th percentile), while EW sits higher in its own history (74th). Within each stock's own 5-year context, COLO-B.CO is at a historically more favourable entry position than EW. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Profitability
On profitability, Edwards Lifesciences Corporation is positioned higher in the group, while Coloplast A/S is closer to the middle.
Valuation
Both sit in the weaker half on valuation, with Coloplast A/S still coming out ahead.
Profitability — Dominant Gap
COLO-B.CO
35
EW
57
Gap+22in favour of EW

The clearest distance comes from a stronger profitability profile.

What keeps the gap from being one-sided

Coloplast A/S still looks less cycle-sensitive — that keeps the result from looking completely one-sided.

What this means for the comparison

The structural lead is real, but pricing and the broader setup still stop short of a fully aligned result.

Explore full peer positioning in AssetNext

Break down the COLO-B.CO vs EW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-valuation comparisons

Explore how COLO-B.CO and EW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.